en

PRODUCT DETAIL

Rhophylac 300 mikrogramov/2 ml

Code 0376B
MA number 59/0397/07-S
Product Form: sol inj 5x2 ml/300 µg (striek.inj.skl.napl.+ihla)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Mutual recognition procedure
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J06 IMMUNE SERA AND IMMUNOGLOBULINS
J06B IMMUNOGLOBULINS
J06BB Specific immunoglobulins
J06BB01 Anti-D (rh) immunoglobulin
Shelf life: 36
Container: glass pre-filled syringe
Route of admin.: Intramuscular or intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 19.11.2007
Pediatric indication: Yes
Pediatric posology: Yes
SPC: SPC_Rhophylac_09.2019.doc  
PIL: PIL Rhophylac_09.2019.doc  
Safety feature Yes
Data update: 07.03.2019
eu-flag.png sk-flag.png